Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer.
Adolfsson
Jan
J
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000008:administration & dosage; D058891:5-alpha Reductase Inhibitors; D018890:Chemoprevention; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000517:prevention & control*; D018570:Risk Assessment; D016896:Treatment Outcome
D058891:5-alpha Reductase Inhibitors; D018120:Finasteride; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase